Trends in the use of antimuscarinics and alpha-adrenergic blockers in women with lower urinary tract symptoms in Taiwan: A nationwide, population-based study, 2007-2012.

Abstract

BACKGROUND:

We aim to examine the trend in the use of antimuscarinics and off-label alpha-adrenergic blockers for treatment of lower urinary tract symptoms (LUTS) in a Taiwanese Women Cohort between 2007 and 2012.

METHODS:

This population-based National Health Insurance Research Database (NHIRD) was used to examine the trends in the use of antimuscarinics or off-label alpha-adrenergic blockers in Taiwan. A sample of 1,000,000 individuals randomly drawn from the whole population of 23 million individuals who were registered in the NHI in 2005. From 2007 through 2012, women aged over 18 years whose claim record contained prescriptions of either of the two drugs for treatment of any of the LUTS-related diagnoses were identified and analyzed. The annual usage of the two drug classes were calculated by defined daily dose (DDD).

RESULTS:

From 2007-2012, there was a 0.80 fold (69676.8 to 125104.3) increase in DDD of antimuscarinics in our cohort. The overall healthcare seeking prevalence of LUTS was 7.33% in 2007 and 12.38% in 2012, in a rising trend. The prevalence of antimuscarinics-treated LUTS in our cohort increased from 2.53 in 2007 to 3.41 per 1000 women in 2012. The prevalence of LUTS treated by antimuscarinics increased especially for those older than 60 years during the study period.

CONCLUSIONS:

This 6-year observational study provided the epidemiologic information of clinically significant LUTS of Asian female population. Moreover, there was a rising trend in the use of antimuscarinics and off-label alpha-adrenergic blockers in the population-based cohort.

• Authors: Yu-Hua Lin, Wei-Yi Huang, Chi-Chih Chang, Yu-Fen Chen, Ling-Ying Wu, Hong-Chiang Chang, Kuo-How Huang
• Journal: PloS one (PLoS One) Vol. 14 Issue 10 Pg. e0220615 ( 2019) ISSN: 1932-6203 [Electronic] United States
• PMID: 31589615 (Publication Type: Journal Article, Randomized Controlled Trial, Research Support, Non-U.S. Gov't)

Chemical References

• Adrenergic alpha-Antagonists
• Muscarinic Antagonists

Topics

• Adolescent
• Adrenergic alpha-Antagonists (administration & dosage)
• Adult
• Aged
• Databases, Factual
• Female
• Humans
• Lower Urinary Tract Symptoms (drug therapy, epidemiology)
• Middle Aged
• Muscarinic Antagonists (administration & dosage)
• National Health Programs
• Prevalence
• Taiwan (epidemiology)